In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest

被引:57
作者
Fleck, Ralf [1 ]
Dietz, Annebaerbel [1 ]
Hof, Herbert [1 ]
机构
[1] Univ Heidelberg, Inst Med Microbiol & Hyg, Fac Clin Med Mannheim, Heidelberg, Germany
关键词
caspofungin; voriconazole; fluconazole; flucytosine; amphotericin B;
D O I
10.1093/jac/dkl555
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The aim of this study is to evaluate the susceptibilities of Candida spp. to the common antifungal agents in a German university hospital. Since quick results of in vitro testing are desirable, Etest and the CLSI broth microdilution (BMD) method (reference method) were compared, focusing on the validity of early readings. Methods: A total of 512 Candida spp. isolates, including 174 from primarily sterile sites, were collected in the clinical routine. The yeasts were differentiated by CHROMagar and verified by API 20C AUX if necessary. In vitro susceptibilities to amphotericin 13, flucytosine, fluconazole, voriconazole and caspofungin were determined using the BMD method described in the CLSI (formerly NCCLS) M27-A2 document and Etest. MICs were noted after 24 and 48 h of incubation. Results: The most frequently isolated species was Candida albicans. Among the non-albicans species, Candida glabrata was the most prevalent, followed by Candida tropicalis, Candida parapsilosis and Candida krusei. MiCs (mg/L) at which 90% of the strains were inhibited were I for amphotericin B, 32 for flucytosine, 8 for fluconazole, 0.25 for voriconazole and 1 for caspofungin. Susceptibility to fluconazole was 85.0% for C. glabrata and 5.3% for C. krusei, almost all other isolates were susceptible in over 90% except very rare species. The 48 h MIC values of Etest and BMD were in agreement (no more than 2 1092 dilutions) in 88.7% to 98.1% with categorical agreement rates of 91.6% to 98.2%, depending on the antifungal agent. Comparison of the 24 h MiCs of both BMD and Etest with the 48 h MiCs of the reference method showed categorical agreement in 94.9% to 99.2%. For caspofungin, however, a comparison of the categorical agreement was not possible due to the lack of interpretive breakpoints. The order of frequency and the resistance patterns of the isolates from primarily sterile sites and those of isolates from non-sterile sites did not differ. Conclusions: No alarming resistances against the agents tested were found; however, owing to the relatively high frequency of C. glabrata with elevated fluconazole MiCs, this species and, to a certain extent, C. krusei must be taken into consideration when choosing antifungal agents for calculated therapy. Etest is a reliable method for the susceptibility testing of Candida spp. and the 24 h readings of both Etest and BMD can serve as helpful preliminary results in most cases.
引用
收藏
页码:767 / 771
页数:5
相关论文
共 10 条
[1]   Quality control limits for broth microdilution susceptibility tests of ten antifungal agents [J].
Barry, AL ;
Pfaller, MA ;
Brown, SD ;
Espinel-Ingroff, A ;
Ghannoum, MA ;
Knapp, C ;
Rennie, RP ;
Rex, JH ;
Rinaldi, MG .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) :3457-3459
[2]   Antifungal drug resistance of pathogenic fungi [J].
Kontoyiannis, DP ;
Lewis, RE .
LANCET, 2002, 359 (9312) :1135-1144
[3]   Candida krusei fungaemia:: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital [J].
Muñoz, P ;
Sánchez-Somolinos, M ;
Alcalá, L ;
Rodríguez-Créixems, M ;
Peláez, T ;
Bouza, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (02) :188-193
[4]  
National Committee for Clinical Laboratory Standards, 2002, M27A2 NCCLS
[5]   Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome [J].
Park, BJ ;
Arthington-Skaggs, BA ;
Hajjeh, RA ;
Iqbal, N ;
Ciblak, MA ;
Lee-Yang, W ;
Hairston, MD ;
Phelan, M ;
Plikaytis, BD ;
Sofair, AN ;
Harrison, LH ;
Fridkin, SK ;
Warnock, DW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) :1287-1292
[6]   Correlation of MIC with outcome for Candida species tested against voriconazole:: Analysis and proposal for interpretive breakpoints [J].
Pfaller, MA ;
Diekema, DJ ;
Rex, JH ;
Espinel-Ingroff, A ;
Johnson, EM ;
Andes, D ;
Chaturvedi, V ;
Ghannoum, MA ;
Odds, FC ;
Rinaldi, MG ;
Sheehan, DJ ;
Troke, P ;
Walsh, TJ ;
Warnock, DW .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (03) :819-826
[7]   International surveillance of bloodstream infections due to Candida species:: Frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY program [J].
Pfaller, MA ;
Jones, RN ;
Doern, GV ;
Sader, HS ;
Hollis, RJ ;
Messer, SA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (07) :1886-1889
[8]   The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy:: antifungal susceptibility patterns of 261 non-albicans Candida isolates from blood [J].
Tortorano, AM ;
Rigoni, AL ;
Biraghi, E ;
Prigitano, A ;
Viviani, MA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (04) :679-682
[9]   COMPARISON OF ETEST AND NATIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS BROTH MACRODILUTION METHOD FOR ANTIFUNGAL SUSCEPTIBILITY TESTING - ENHANCED ABILITY TO DETECT AMPHOTERICIN B-RESISTANT CANDIDA ISOLATES [J].
WANGER, A ;
MILLS, K ;
NELSON, PW ;
REX, JH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) :2520-2522
[10]   INCREASE IN CANDIDA-KRUSEI INFECTION AMONG PATIENTS WITH BONE-MARROW TRANSPLANTATION AND NEUTROPENIA TREATED PROPHYLACTICALLY WITH FLUCONAZOLE [J].
WINGARD, JR ;
MERZ, WG ;
RINALDI, MG ;
JOHNSON, TR ;
KARP, JE ;
SARAL, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (18) :1274-1277